Children with relapsed or refractory nephroblastoma : favorable long-term survival after high-dose chemotherapy and autologous stem cell transplantation
- Weitere Titel
-
Vorteilhaftes Langzeitüberleben von Kindern mit rezidivierten Nephroblastomen nach Hochdosis-Chemotherapie und autologem Stammzellrescue
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Klinische Pädiatrie, 226.2014, Heft 6-7, S. 351-356, doi:10.1055/s-0034-1390504
- Schlagwort
-
Pädiatrie
Kinderkrankheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main
- (wer)
-
Universitätsbibliothek Johann Christian Senckenberg
- (wann)
-
2014
- Urheber
- URN
-
urn:nbn:de:hebis:30:3-358097
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Illhardt, Toni
- Ebinger, Martin
- Schwarze, Carl Philipp
- Feuchtinger, Tobias F.
- Furtwängler, Rhoikos
- Schlegel, Paul-Gerhardt
- Klingebiel, Thomas
- Greil, Johann
- Beck, James F.
- Handgretinger, Rupert
- Lang, Peter
- Universitätsbibliothek Johann Christian Senckenberg
Entstanden
- 2014
Ähnliche Objekte (12)
Children with Relapsed or Refractory Nephroblastoma: Favorable Long-term Survival after High-dose Chemotherapy and Autologous Stem Cell Transplantation
Analysis of Relapsed/Refractory Hodgkin Lymphoma Treated with Autologous Transplantation: A Single-Center Experience
Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective
High-dose chemotherapy with autologous hematopoietic stem cell transplantation in relapsed or refractory primary CNS lymphoma : a retrospective monocentric analysis of long-term outcome, prognostic factors, and toxicity
Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
High IKZF1/3 protein expression is a favorable prognostic factor for survival of relapsed/refractory multiple myeloma patients treated with lenalidomide
Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Management of relapsed-refractory diffuse large B cell lymphoma
Management of Relapsed and Refractory Multiple Myeloma: Recent advances
Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies
Children with Relapsed or Refractory Nephroblastoma: Favorable Long-term Survival after High-dose Chemotherapy and Autologous Stem Cell Transplantation
Analysis of Relapsed/Refractory Hodgkin Lymphoma Treated with Autologous Transplantation: A Single-Center Experience
Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective
High-dose chemotherapy with autologous hematopoietic stem cell transplantation in relapsed or refractory primary CNS lymphoma : a retrospective monocentric analysis of long-term outcome, prognostic factors, and toxicity
Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
High IKZF1/3 protein expression is a favorable prognostic factor for survival of relapsed/refractory multiple myeloma patients treated with lenalidomide
Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Management of relapsed-refractory diffuse large B cell lymphoma
Management of Relapsed and Refractory Multiple Myeloma: Recent advances
Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies
Children with Relapsed or Refractory Nephroblastoma: Favorable Long-term Survival after High-dose Chemotherapy and Autologous Stem Cell Transplantation
Analysis of Relapsed/Refractory Hodgkin Lymphoma Treated with Autologous Transplantation: A Single-Center Experience
Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective
High-dose chemotherapy with autologous hematopoietic stem cell transplantation in relapsed or refractory primary CNS lymphoma : a retrospective monocentric analysis of long-term outcome, prognostic factors, and toxicity
Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
High IKZF1/3 protein expression is a favorable prognostic factor for survival of relapsed/refractory multiple myeloma patients treated with lenalidomide
Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Management of relapsed-refractory diffuse large B cell lymphoma
Management of Relapsed and Refractory Multiple Myeloma: Recent advances